• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Half of Providers Unsure of ICD-10 Revenue Impact

by Fred Pennic 11/07/2014 Leave a Comment

ICD-10 Revenue Impact

Nearly half of healthcare providers are unsure of the ICD-10 revenue impact or have yet conducted revenue impact assessments, according to a new eHealth Initiative (eHI)/AHIMA survey. In fact, 35 percent
believed that their organization’s revenue will decrease during the first year of ICD-10 compliance.

The report provides a look at just how prepared healthcare organizations are for the upcoming ICD-10 implementation and how they think ICD-10 will impact their operations. Survey respondents expressed a mix of optimism and concern regarding the impact of ICD-10 indicating that coding (59%), documenting patient encounters (42%) and adjusting reimbursement claims (41%) would be the most difficult under ICD-10. 

ICD-10 End to End Testing

ICD-10 End-to-end testing is an important step in assessing ICD-10 readiness in which all external parties/business partners systems are testing to closely mirror real-world scenarios. The survey found: 

– 65 percent of respondents indicated that they could begin end-to-end testing prior to the fourth quarter of 2015, when compliance is set to begin. 

– 63 percent will be ready to conduct testing in 2014, while the rest will wait until 2015. 

– 10 percent of all respondents currently have no plans to conduct end-to-end testing, and 17 percent don’t know when their organization will be ready for testing. 

– 36 percent of healthcare organizations with no plans to conduct end-to-end testing often cited a lack of knowledge as the reason to forego testing.

– 45 percent of these organizations are clinics/physician practices, possibly indicating a knowledge gap around ICD-10 implementation and testing for those organizations with fewer resources.

Challenges

Respondents cited a number of key challenges including: 

– Claims processing (58%)

– Clinical Workflow and Productivity (56%)

– Lack of Staff (49%)

– Change Management (48%)

– Vendor/Partner Readiness (47%)

Recommendations

The key findings demonstrate that many of the survey respondents are unaware of their state of ICD-10 readiness, indicating a lack of communication and collaboration about the transition. Organizations should consider the following recommendations: 

1. Test early and frequently

Testing should occur during all stages of implementation, not only in an end-to-end environment. Stakeholders should test systems as they work with their vendors to make upgrades and communicate with all of the individuals involved in the claims pathway to ensure that the system functions properly for all roles involved. Furthermore, testing should not focus only on the technical systems, but also the workflows, processes, and supporting elements necessary to use the systems properly. 

2. Collaborate

Stakeholders should reach out to peers and other organizations in their region to share best practices. Regional collaboration may also help improve testing capabilities. Some
clearinghouses have worked with multiple clients at the same time to send batches of test claims and streamline the testing process.

3. Mitigate risk prior to implementation

Strategies such as dual coding can help organizations mitigate the risk of the impact of ICD-10 by familiarizing staff with the new code set in advance of implementation, thus improving coding accuracy and productivity. Documentation improvement can similarly help prepare staff for the increased specificity of ICD-10 and highlight areas where
documentation will need to change. Because the impact of ICD-10 will not be uniform across an organization, operational and/or financial impact assessments can reveal potential variation across service lines and enable the organization to more appropriately target resources prior to implementation.

Survey Demographics

 – 73 percent of survey respondents were primarily from healthcare delivery organizations

– Among these, acute care hospitals (30%) and clinics/physician practices (25%) were most common.

– While physician practices tended to be smaller, 58 percent had only one to four physicians; hospitals varied in size. 

– The roles of respondents at their organizations ranged from managers (32%) to directors (24%) to executives (16%). Ten percent were clinicians.

Tagged With: ICD-10 Revenue Impact

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |